Introduction Executive Summary Chikungunya virus infections: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Chikungunya virus infections – DelveInsight’s Analytical Perspective Late Stage Products (Phase III) • Comparative Analysis VLA1553: Valneva • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis Chikungunya virus vaccine: Themis Bioscience • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis mRNA 1944: Moderna Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical and Discovery Stage Products • Comparative Analysis Research programme: chikungunya vaccine: Emergex Vaccines • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Chikungunya virus infections Key Companies Chikungunya virus infections Key Products Chikungunya virus infections- Unmet Needs Chikungunya virus infections- Market Drivers and Barriers Chikungunya virus infections- Future Perspectives and Conclusion Chikungunya virus infections Analyst Views Chikungunya virus infections Key Companies Appendix

Table 1 Total Products for Chikungunya virus infections Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Valneva • Moderna Therapeutics • Immunomodulation • Ridgeback Biotherapeutics • Etubics Corporation • Themis Bioscience • FIT Biotech • Bharat Biotech • Emergex Vaccines • Emergent BioSolutions • Indian Immunologicals Ltd. • Auro Vaccines